drugset / Trial / NCT05977699

Reversibility of Methacholine Induced Bronchoconstriction

NCT05977699

Phase 4 Completed 16 enrolled University of Saskatchewan
RandomizedCrossoverTriple-blindTreatment

Summary

The study will compare salbutamol reversibility of methacholine induced bronchoconstriction between a pressurized metered dose inhaler with a spacer versus nebulizer administration using a vibrating mesh nebulizer.

Timeline

Start
2024-01-12
Primary completion
2024-11-25
Completion
2024-11-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown 200 ug Inhaled

Indications